Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 347

Lessons from a century of virus plagues

Last month, traders seemed to be shrugging collectively at the coronavirus in assuming China had been largely successful containing the outbreak to epidemic rather than pandemic levels.

How quickly things change. Markets plunged at the end of February after reports of outbreaks in Japan, South Korea, Italy and Iran. As we can see below, traders shifted (at least temporarily) from complacency to panic.

However, volatile and unpredictable markets have more recently delivered two 4% rallies in the US in three days after Congress authorised virus prevention spending and the Federal Reserve cut interest rates. Share prices will remain under pressure as analysts consider how coronavirus will affect company earnings and the broader global economy.

The good news for investors is that the world’s governments are hell-bent on avoiding recession. At first, Australia's Prime Minister Scott Morrison had ruled out fiscal stimulus to prop up the local economy, but soon changed tack as he floated the option of stimulus to combat a global pandemic.

The challenge of the coronavirus is that it isn’t deadly enough.

The H5N1 avian flu has a mortality rate of 60%, but because it is so deadly there are few opportunities for widespread infection.

On the other hand, the common flu has a mortality rate of less than 0.1% but is easily spread due to its relatively mild symptoms. Most people don’t experience severe symptoms with the coronavirus, meaning they are likely to infect others before being diagnosed.

When major news outlets are running headlines like this, it’s little surprise that investors are wondering whether they should be battening down the hatches.

For long-term investors, the question is whether the coronavirus is going to have lasting implications for investor portfolios.

Investing timeframes should be years and decades, not days and weeks, and markets cannot be timed perfectly. As we can see below, failing to time the markets correctly is a costly proposition.

Comparing previous virus plagues

There have been three major pandemics over the past 100 years, which have killed millions of people not just the odd thousand or so. In terms of their effect on share markets, the chart below shows the total returns including dividends but after inflation for Australian (green) and US (red) shares since 1900.

1918-19 ‘Spanish’ flu A/H1N1

The victims of the 1918-19 Spanish Flu were mainly healthy individuals between 20- and 50-years-old, in stark contrast to other pandemics that affected mainly infants and the elderly.

Spanish Flu was first observed in Europe, the US and across Asia but swiftly spread around the world.

In Australia, 40% of the total population was infected and 15,000 people died. We had one of the lowest death rates globally, at just 2.7 deaths per 1,000 population. The Federal government set up the Commonwealth Serum Laboratories (now CSL) near the end of the War to develop local vaccines and its first major success was a vaccine for Spanish Flu.

Despite infecting one third of the world’s population, killing 50 million people and hospitalising hundreds of millions more, the impact on share markets was limited.

In the immediate post-war years, share markets were hit by a massive bout of post-war inflation (20%+ in Australia and the US) and equally damaging fiscal and monetary tightening to fight inflation. If anything, the deaths of 50 million people and spending cuts by hundreds of millions who were infected may well have prevented the inflation spikes from being worse than they turned out to be.

In any event, once the inflation was brought down by sharp recessions in 1920-21, share prices took off and started the long 1920s boom driven by post-war housing, urbanisation and new technology – motor cars, radios and other household appliances.

1957 ‘Asian flu’ A/H2N2 virus

It is thought to have started from animal and human H1N1, and avian H2N2 virus strains, in China's Yunnan province before spreading through Hong Kong to the rest of the world. The Asian flu killed between 1 million and 2 million people worldwide, mainly infants and the elderly, including 70,000 Americans but only 2 in Australia.

Shares were unaffected by the crisis and kept rising in Australia and the US during the great 1950s post-World War 2 boom that was fuelled in both countries by housing, infrastructure and consumer finance – not unlike the 1920s post-WW1 share boom.

1968-70 ‘Hong Kong flu’ A/H3N2

This pandemic came in two waves across the world, the first in 1968-69 and second in 1969-70. It is thought to have originated as a mixed infection of an animal with human H2N2 and avian H3Nx virus strains in Asia. It killed around 1 million people globally, mainly elderly, including 34,000 Americans and 2,400 Australians.

At the time, share markets were enjoying the 1960s ‘space race’/ aeronautics boom in the US. This surge triggered the speculative mining boom in Australia, especially in metals like nickel which was used in aeronautics, and was also in high demand for armaments in the Vietnam War.

2009-10 – ‘Swine Flu’ or ‘Mexican flu’ – H1N1

This originated in Mexico and spread around the world, infecting between 700 million and 1.4 billion people and killing about 200,000, mainly the young, including 12,000 Americans and 1,600 Australians.

For shares, 2009-10 was of course the great rebound from the GFC share market crash. Share prices powered through the flu pandemic and other crises including:

  • the European bank runs
  • first Greek debt bailout
  • Iceland and Irish bankruptcies and bailouts
  • Dubai debt crisis.

Where to from here?

No cure or vaccine for the coronavirus has been developed yet, so the infection rate and death toll are probably going to keep spreading rapidly. But the rate of spread appears to be slowing.

In January the growth rate of infection was running at 50% per day, but fell to 30% per day in early February, and now appears to be 15% per day (on official figures anyway).

The growth rate makes a difference.

At 50% per day it would take just 30 days to infect the entire world population.

At 30% per day it would take 45 days; and at 15% per day it would take 85 days.

If not contained, at 5% per day it would take 250 days to infect the whole world.

More likely outcomes would be a continued slowing in the rate of spread of the infection, and/or containment or vaccine.

Most of the impacts are likely to be short term, either pulling spending forward that would otherwise have been spent later (eg purchases of food, durable goods stockpiled, vitamins, etc), or delaying spending that would be picked up later (factory production, car purchases, travel, etc).

Long-term investors should be focussed on more long-lasting or permanent changes.

50 million people dying of the Spanish Flu took 50 million potential workers and consumers out of the market permanently, but that was right at the start of the tremendous 1920s boom.

Likewise, the 1-2 million people taken out by the late 1950s Asian flu and the late 1960s Hong Kong flu, plus tens of millions infected temporarily in each case, had little impact on markets.

On the other hand, the 1340s-50s Black Death that wiped out one fifth of the global population including at least one third of Europe no doubt would have had large and long-lasting effects on economic output, company profitability and the holders of government and corporate debt.

 

Ashley Owen is Chief Investment Officer at advisory firm Stanford Brown and The Lunar Group. He is also a Director of Third Link Investment Managers, a fund that supports Australian charities. This article is for general information purposes only and does not consider the circumstances of any individual.

 

5 Comments
Phil
March 08, 2020

The chart provides great long term perspective, no doubt. But generally that is not the problem, the problem is in that acute 18 months to 2 years before the boom recovery where investors lose the faith or become insolvent, lose jobs etc. Where the practicality begins.

Josh
March 08, 2020

"On the other hand, the 1340s-50s Black Death that wiped out one fifth of the global population including at least one third of Europe no doubt would have had large and long-lasting effects on economic output, company profitability and the holders of government and corporate debt."

considering "company profitability" in the face of the black death is an odd slant to be interested in...

But anyway, it is interesting to compare to your statement that 50 million deaths from the Spanish flu preceded the booms of the 20s.

In fact, the Black plague of the 14th Century fundamentally changed the course of human history, as it dramatically increased the prices of wages, particularly in western Europe. Of course, the impact would not have been immediate, but it can't be too coincidental that a generation or two later, in the middle of the millenia, we start seeing huge leaps in living standards, which spurred giant leaps in science and technology shortly thereafter.

SMSF Trustee
March 10, 2020

No antibiotics in the 14th century, or even during the Spanish flu. Many deaths in the latter were from World War 1 injured people who couldn't cope with getting the virus, or from secondary infections for which there was no treatment. Not saying medicine solves all problems, but these simplistic historical comparisons are actually not helpful guides to understanding the COVID19 situation.
Please, let's stop talking ourselves into unnecessary worry.

Let's not blame the virus for the fall in the stock market or the possible economic recession that it's foretelling. Let's blame human behaviour - both the poor response of governments to the situation, and the ridiculous fear reactions of so many people.

Lisa
March 04, 2020

Can you add comment about SARS and Ebola, and the Zika?

Steve
March 04, 2020

Then there's always this:


Six Reasons Why Covid-19 Fails The Sniff Test
https://www.zerohedge.com/health/six-reasons-why-covid-19-fails-sniff-test

 

Leave a Comment:

RELATED ARTICLES

A world out of sync with inflation

Decide if 'fake crises' are worth the worry

How likely are market crashes?

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.